Answers are grounded in this paper and cite their sources.
Objective: Neuroprotective potential of recombinant human erythropoietin (rhEpo) was reported in various experimental models of brain damage but the exact mechanism of its effect is still unclear. In the present study, the effect of rhEpo administration on the level of neuronal loss and neurodegenerative changes in the dorsolateral band of the entorhinal cortex and ventral posteriomedial nucleus of the thalamus in rats following focal cerebral ischemia was examined.
No takes yet. Share an insight, caveat, or question.
Jasenka et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: